CClinicalTrials.gg
CompletedNCT00860444HHERUpdated Jan 7, 2014

Cardiovascular Risk Reduction Program Aimed at African American Women (The HHER Lifestyle Program)

A Phase 3 interventional study of Basic Educational and Counseling Program and Comprehensive Educational and Counseling Program in Cardiovascular Diseases, sponsored by The University of Texas Health Science Center at San Antonio. Completed. Open to female participants aged 35 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-01-07.

Sponsored by The University of Texas Health Science Center at San Antonio · Phase 3, Interventional, and Prevention

Phase
Phase 3
Study type
Interventional
Enrollment
266
Allocation
Randomized
Ages
35 Years and older
Sex
Female
01

Study summary

Cardiovascular disease (CVD) is a serious health problem among African American women. This study will evaluate a health care center-based program that aims to encourage African American women to eat a low fat diet and increase their physical activity levels to reduce the risk of developing CVD.

Read the detailed description

CVD is the leading cause of death for women in the United States. It affects African American women at a higher rate than it does white women. People at risk for CVD are encouraged to maintain a healthy weight, eat a healthy diet that is low in fat and cholesterol, and increase their physical activity. Heath care centers are excellent places to provide counseling to people on ways to reduce their risk of CVD. In this study, researchers will evaluate the effectiveness of a community health care center-based counseling program aimed at reducing CVD risk factors among African American women from financially disadvantaged backgrounds.

This study will enroll African American women. Participants will be randomly assigned to one of two groups-either a basic program or a comprehensive program. During a routine, scheduled visit with their health care providers, all participants will learn about the importance of increasing physical activity and eating a low fat diet. All participants will also receive educational materials and a community resource guide. In addition to this, participants in the comprehensive program will receive a pedometer and will be asked to keep a daily log of their physical activity and eating habits. Once a month, these same participants will receive telephone calls from a health counselor and a newsletter by mail that encourages them to maintain a healthy lifestyle. All participants will receive home visits from study staff at baseline and Months 6 and 12. During these visits, participants will undergo blood pressure, weight, height, and waist measurements and a blood collection. Participants will complete questionnaires to assess their medical history, diet, and physical activity habits. For 1 week after each visit, participants will wear a physical activity monitor and keep an activity diary.

02

Conditions studied

  • Cardiovascular Diseases

Keywords

  • Primary Care
  • Diet
  • Physical Activity
03

In context

Cardiovascular Diseases

4,902 studies on the registry are indexed under Cardiovascular Diseases; 920 are open to participants now.

This study's enrollment of 266 is above the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

The University of Texas Health Science Center at San Antonio is the lead sponsor of 435 studies on the registry; 88 are open to participants now.

Of its 62 completed or terminated interventional studies of FDA-regulated products, 31 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • African American women
  • Able and willing to complete survey instruments and assessment procedures

Exclusion criteria

Exclusion Criteria:

  • Physical disability or orthopedic problem that limits physical activity
  • Elevated blood pressure (i.e., greater than 160/95 mm Hg)
  • Insulin-dependent diabetes
  • Pregnant or planning to become pregnant during the study period
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
266 participants (actual)

Study arms

  • Active comparator
    1

    Participants will take part in the basic educational and counseling program through their community health care center.

    Behavioral: Basic Educational and Counseling Program

  • Experimental
    2

    Participants will take part in the comprehensive educational and counseling program through their community health care center.

    Behavioral: Comprehensive Educational and Counseling Program

Interventions

  • BehavioralBasic Educational and Counseling Program

    Participants will receive one session of brief patient-centered physician counseling, along with educational handouts and nurse-assisted guidance with goal-setting.

  • BehavioralComprehensive Educational and Counseling Program

    Participants will receive one session of brief patient-centered physician counseling, along with educational handouts and nurse-assisted guidance with goal-setting. They will also receive 12 months of telephone counseling and a monthly newsletter.

06

What researchers measure

Primary outcomes

  1. Hours per week in moderate and vigorous intensity physical activities (MVPA), as measured by the Community Healthy Activities Model Program for Seniors (CHAMPS) Physical Activity Questionnaire

    Time frame: Measured at baseline and Months 6 and 12

  2. Weekly consumption frequency of dietary fat and cholesterol, as measured by the New Leaf Dietary Risk Assessment (DRA)

    Time frame: Measured at baseline and Months 6 and 12

Secondary outcomes

  1. Body mass index (weight [kg]/height [m2])

    Time frame: Measured at baseline and Months 6 and 12

  2. Central adiposity (i.e., waist circumference in inches)

    Time frame: Measured at baseline and Months 6 and 12

  3. Total cholesterol (mg/dL)

    Time frame: Measured at baseline and Months 6 and 12

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Parra-Medina D, Wilcox S, Wilson DK, Addy CL, Felton G, Poston MB. Heart Healthy and Ethnically Relevant (HHER) Lifestyle trial for improving diet and physical activity in underserved African American women. Contemp Clin Trials. 2010 Jan;31(1):92-104. doi: 10.1016/j.cct.2009.09.006. Epub 2009 Sep 22. PubMed 19781665 ↗
  • Parra-Medina D, Wilcox S, Salinas J, Addy C, Fore E, Poston M, Wilson DK. Results of the Heart Healthy and Ethnically Relevant Lifestyle trial: a cardiovascular risk reduction intervention for African American women attending community health centers. Am J Public Health. 2011 Oct;101(10):1914-21. doi: 10.2105/AJPH.2011.300151. Epub 2011 Aug 18. PubMed 21852629 ↗
  • Wilcox S, Parra-Medina D, Felton GM, Poston MB, McClain A. Adoption and implementation of physical activity and dietary counseling by community health center providers and nurses. J Phys Act Health. 2010 Sep;7(5):602-12. doi: 10.1123/jpah.7.5.602. PubMed 20864755 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00860444
Lead sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Deborah Parra-Medina (Professor, Epidemiology and Biostatistics, The University of Texas Health Science Center at San Antonio) — Principal investigator
First posted
Mar 12, 2009
Start date
May 2005
Primary completion
Apr 2008
Completion
Apr 2008
Last update
Jan 7, 2014

Study contacts

Deborah Parra-Medina, PhD
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion